CIMAvax: The Cuban Lung Cancer Vaccine Explained

Click here to get this post in PDF

Dr. Kelvin Lee, Chair of the Department of Immunology at Roswell Park Cancer Institute, shares the groundbreaking potential of CIMAvax-EGF, a lung cancer vaccine developed in Cuba. Learn more:

What we know so far: 0:00
The innovation that led to CIMAvax: 1:09
Benefits for high-risk patients: 2:02
The future of CIMAvax: 4:12
The science behind CIMAvax: 5:15
The safety of CIMAvax: 5:47
The Cuban collaboration: 6:17